IUSCCC Grand Rounds 12/2/2022: " Preclinical Development of Agents with Combined Antitumor and Base Anabolic Activity for Multiple Myeloma" Attaya Suvannasankha, MD

From Kristen Scott December 2nd, 2022

views comments

" Preclinical Development of Agents with Combined Antitumor and Base Anabolic Activity for Multiple Myeloma" Attaya Suvannasankha, MD, Associate Professor of Clinical Medicine, Department of Medicine, Division of Hematology/Oncology IUSM

Tags

Looking for more...